CD163 and cardiovascular disorder: In cardiovascular disease, CD163+ elevation elicits the differentiation of a distinct, alternative, non–foam-cell anti-inflammatory macrophage that, in turn, promotes angiogenesis, leakiness, inflammation, and plaque progression via the CD163/HIF1α/VEGF-A pathway (108).